by
Vanessa N. Raabe;
Gerrit Kann;
Bruce Ribner;
Andres Morales;
Jay Varkey;
Aneesh Mehta;
George Lyon III;
Sharon Vanairsdale;
Kelly Faber;
Stephan Becker;
Markus Eickmann;
Thomas Strecker;
Shelley Brown;
Ketan Patel;
Philipp De Leuw;
Gundolf Schuettfort;
Christoph Stephan;
Holger Rabenau;
John D. Klena;
Pierre E. Rollin;
Anita McElroy;
Ute Stroher;
Stuart Nichol;
Colleen Kraft;
Timo Wolf
Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir. Both patients survived but developed transaminitis and had prolonged detectable virus RNA in blood and semen, suggesting that the possibility of sexual transmission of Lassa virus should be considered.